Panacea, SII conducting trials to develop dengue vaccine: DG ICMR Ruchika Sharma17 May 2023 2:30 PM ISTNew Delhi: Two companies are conducting trials to develop a dengue vaccine, Director General, Indian Council of Medical Research Dr Rajeev Bahl told...
Japan's Takeda Pharma profit slips 13 percent, pipeline bolsters outlook Ruchika Sharma5 Feb 2023 10:00 AM ISTThe company said core operating profit, which strips out non-recurring items, increased 26 percent in the nine-month period.
Takeda Dengue Tetravalent Vaccine QDENGA gets European Commission nod Ruchika Sharma10 Dec 2022 10:00 AM ISTQDENGA (TAK-003) is a dengue vaccine that is based on a live-attenuated dengue serotype 2 virus, which provides the genetic “backbone” for all four...
Takeda Dengue Vaccine TAK-003 gets USFDA priority review Ruchika Sharma23 Nov 2022 5:00 PM ISTTakeda's tetravalent dengue vaccine candidate (TAK-003) is based on a live-attenuated dengue serotype 2 virus, which provides the genetic "backbone"...
Takeda gets positive CHMP opinion recommending nod of Dengue Vaccine in EU, Dengue-endemic countries Ruchika Sharma16 Oct 2022 12:00 PM ISTJapan: Takeda has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
Takeda dengue vaccine TAK-003 provides continued protection against dengue fever through 4.5 years in trial Roshni Dhar11 Jun 2022 5:06 PM ISTTakeda has announced that its dengue vaccine candidate, TAK-003, prevented 84% of hospitalized dengue cases and 61% of symptomatic cases, with no...
Health Bulletin 11/6/2022 Roshni Dhar11 Jun 2022 4:27 PM ISTHere are the top health stories for the day:NMC orders crackdown on referral fee, commissions, and online procurement of patients ...
Takeda Dengue vaccine TAK-003 provides continued protection against dengue fever through 4.5 years in trial Ruchika Sharma11 Jun 2022 10:00 AM ISTNew Delhi: Takeda has announced that its dengue vaccine candidate, TAK-003, prevented 84% of hospitalized dengue cases and 61% of...
Takeda's dengue vaccine efficacious, decreases hospitalization in adolescents MD Editorial Team8 Nov 2021 10:00 AM ISTTakeda's live attenuated tetravalent dengue vaccine candidate (TAK-003) will be the first dengue vaccine to be cleared for use in India if approved. ...
Clarify, revise protocol for phase 3 trial of Dengue Tetravalent Vaccine: CDSCO panel tells Panacea Biotec Medical Dialogues Team2 Oct 2021 11:30 AM ISTNew Delhi: In response to Panacea Biotec's proposal to conduct a phase 3 clinical trial of its Dengue Tetravalent Vaccine, the Subject Expert...
Takeda starts Dengue vaccine regulatory submissions in EU, dengue-endemic nations Ruchika Sharma28 March 2021 10:00 AM ISTJapan: Takeda Pharmaceutical Company Limited has recently announced that the European Medicines Agency (EMA) has accepted the Company's...
AIIMS symposium to deliberate upon Dengue vaccine in India savita thakur thakur29 April 2017 12:53 PM ISTNew Delhi: A symposium by AIIMS in collaboration with France will deliberate upon launching clinical trials to establish the safety and efficacy of...
